Selenophosphate synthetase 1 (SEPHS1) promotes the expression of SMADs in liver cancer cells and stimulates the migration and invasion of tumors induced by TGF-β, which is negatively correlated with the OS and RFS of HCC patients (Yang et al., 2021). This evidence concerns the gene TGFB1 and hepatocellular carcinoma.